Atlas Trials

A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease

Clinical trial NCT04365218 · COMPLETED

Trial details

NCT number
NCT04365218
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2020-07-22
Primary completion
2021-01-03
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.